What is Atb Cap Markets’ Forecast for Curaleaf Q1 Earnings?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Investment analysts at Atb Cap Markets issued their Q1 2025 earnings per share estimates for shares of Curaleaf in a research note issued on Tuesday, March 4th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.05) per share for the quarter. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Atb Cap Markets also issued estimates for Curaleaf’s Q2 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.19) EPS.

CURLF has been the subject of several other reports. Roth Capital upgraded Curaleaf to a “strong-buy” rating in a research report on Sunday, November 10th. Cormark downgraded Curaleaf from a “moderate buy” rating to a “hold” rating in a research report on Thursday, November 7th.

Curaleaf Price Performance

Shares of CURLF stock opened at $1.04 on Friday. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. Curaleaf has a twelve month low of $0.88 and a twelve month high of $6.40. The company has a market cap of $687.05 million, a P/E ratio of -3.59 and a beta of 0.57. The business has a fifty day simple moving average of $1.43 and a 200 day simple moving average of $2.17.

Curaleaf (OTCMKTS:CURLF) last released its earnings results on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. The firm had revenue of $331.05 million during the quarter, compared to the consensus estimate of $331.87 million.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.